Scorpius Holdings, INC

Market Movers (8-K)

OTC.Pink
Scorpius Holdings, Inc. announced the immediate resignation of three board members, including the chairs of the Audit, Compensation, and Nominating committees.
Worse than expected
OTC.Pink
Scorpius Holdings, Inc. completed the foreclosure sale of substantially all its non-cash assets, including its CDMO and R&D operations, to partially settle $30.2 million in secured debt.
Worse than expected
OTC.Pink
Scorpius Holdings, Inc. has issued four non-convertible secured promissory notes totaling $239,539.77 to an institutional investor, bearing 5.0% interest and a 15% premium on repayment.
Capital raise
Worse than expected
OTC.Pink
Scorpius Holdings, Inc. has extended the maturity date of a $2.25 million convertible promissory note with a related party to March 1, 2026.
Worse than expected
Capital raise
Delay expected
OTC.Pink
Scorpius Holdings, Inc. has issued three non-convertible secured promissory notes totaling $797,020 to an institutional investor, 3i, L.P., with a 5.0% interest rate and a 15% premium on repayment.
Worse than expected
Capital raise
OTC.Pink
Scorpius Holdings, Inc. has issued a $122,000 non-convertible secured promissory note to 3i, L.P. with a 5.0% annual interest rate and a maturity date of May 20, 2026.
Capital raise

Quarterly Earnings (10-Q)

OTC.Pink
Scorpius Holdings, Inc. has ceased all operations, sold its primary assets, and faces substantial doubt about its ability to continue as a going concern after defaulting on significant debt.
Worse than expected
Capital raise
Delay expected
OTC.Pink
Scorpius Holdings, Inc. reported a substantial increase in net loss, delisting from NYSE American, and defaults on debt obligations, raising significant going concern doubts.
Worse than expected
Capital raise
Delay expected
OTC.Pink
Scorpius Holdings, a contract development and manufacturing organization, saw revenue growth in Q3 2024 but continues to face significant losses and going concern challenges.
Worse than expected
Capital raise
OTC.Pink
Scorpius Holdings, a contract development and manufacturing organization, reported increased revenue in the second quarter of 2024, but continues to face significant financial challenges and going concern uncertainty.
Worse than expected
Capital raise
OTC.Pink
Scorpius Holdings, Inc. reports increased revenue driven by its CDMO services, but continues to face going concern challenges.
Worse than expected
Delay expected
Capital raise

Annual Reports (10-K)

OTC.Pink
Scorpius Holdings grapples with NYSE American delisting, significant losses, and a search for strategic options as it navigates a challenging financial landscape.
Delay expected
Capital raise
Worse than expected
OTC.Pink
Scorpius Holdings, Inc.'s 10-K filing outlines its common stock structure, shareholder rights plan, and anti-takeover provisions, while also detailing its shift towards biomanufacturing.
Delay expected
Capital raise
Worse than expected

Insider Trading (Form 4)

OTC.Pink
Jeffrey Alan Wolf, CEO of Scorpius Holdings, acquired 2,500,000 shares of common stock and warrants to purchase an additional 2,500,000 shares as part of a $6 million securities issuance by the company.
Capital raise

Proxy Statements (Def-14A)

OTC.Pink
Scorpius Holdings is asking stockholders to approve a reverse stock split and a share issuance to maintain compliance with NYSE American listing rules and facilitate future financing.
Capital raise
OTC.Pink
Scorpius Holdings is asking stockholders to approve a reverse stock split, an amendment to its stock incentive plan, and the conversion of a promissory note at its upcoming annual meeting.
Capital raise
Worse than expected

New Public Companies (S-1)

OTC.Pink
Scorpius Holdings is conducting a public offering of up to 26,315,789 shares of common stock and pre-funded warrants to raise capital for working capital and general corporate purposes.
Worse than expected
Capital raise
OTC.Pink
Scorpius Holdings seeks to raise capital through a public offering of up to 29.4 million shares of common stock and pre-funded warrants.
Worse than expected
Capital raise
OTC.Pink
Scorpius Holdings is registering the resale of up to 47.4 million shares of common stock by existing shareholders, stemming from a recent private placement involving convertible notes and warrants.
Worse than expected
Capital raise
OTC.Pink
Scorpius Holdings launches a public offering of common stock and pre-funded warrants, aiming to raise $11.1 million, while preparing for a return to trading on the NYSE American.
Worse than expected
Capital raise
OTC.Pink
Scorpius Holdings files for a public offering of common stock and pre-funded warrants to raise approximately $11.1 million net proceeds, while simultaneously appealing its delisting from the NYSE American.
Worse than expected
Capital raise
OTC.Pink
Scorpius Holdings has filed a registration statement to register $1.38 million in shares of common stock issuable upon the exercise of warrants.
Capital raise

Schedule 13G - Passive Investments

OTC.Pink
3i, LP, 3i Management LLC, and Maier Joshua Tarlow have filed an Amendment No. 2 to their Schedule 13G, disclosing a 9.99% beneficial ownership stake in Scorpius Holdings, Inc.
Capital raise
OTC.Pink
3i, LP, along with 3i Management LLC and Maier Joshua Tarlow, filed an amendment to their Schedule 13G, reporting a 9.99% beneficial ownership stake in Scorpius Holdings, Inc.
OTC.Pink
3i LP, along with its affiliates, has reported a 9.9% beneficial ownership stake in Scorpius Holdings, Inc., primarily through a senior secured convertible note.
Capital raise
OTC.Pink
3i, LP, along with 3i Management LLC and Maier Joshua Tarlow, have filed an Amendment No. 2 to their Schedule 13G, indicating they are no longer beneficial owners of more than 5% of Scorpius Holdings, Inc.'s common stock.
OTC.Pink
An amended Schedule 13G filing reveals that 3i, LP, 3i Management LLC, and Maier Joshua Tarlow collectively hold a 9.9% beneficial ownership stake in Scorpius Holdings, Inc., comprising direct shares, warrants, and a convertible note.
Capital raise